Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 702

1.

Tau, s-100 calcium-binding protein B, and neuron-specific enolase as biomarkers of concussion-reply.

Shahim P, Blennow K, Zetterberg H.

JAMA Neurol. 2014 Jul 1;71(7):926-7. doi: 10.1001/jamaneurol.2014.1160. No abstract available.

PMID:
25023557
[PubMed - in process]
2.

Exploring Alzheimer Molecular Pathology in Down's Syndrome Cerebrospinal Fluid.

Portelius E, Soininen H, Andreasson U, Zetterberg H, Persson R, Karlsson G, Blennow K, Herukka SK, Mattsson N.

Neurodegener Dis. 2014 Jun 27. [Epub ahead of print]

PMID:
24992945
[PubMed - as supplied by publisher]
3.

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.

Hansson O, Hall S, Ohrfelt A, Zetterberg H, Blennow K, Minthon L, Nägga K, Londos E, Varghese S, Majbour NK, Al-Hayani A, El-Agnaf OM.

Alzheimers Res Ther. 2014 May 7;6(3):25. doi: 10.1186/alzrt255. eCollection 2014.

PMID:
24987465
[PubMed]
Free PMC Article
4.

Targeting synaptic pathology with a novel affinity mass spectrometry approach.

Brinkmalm A, Brinkmalm G, Honer WG, Moreno JA, Jakobsson J, Mallucci GR, Zetterberg H, Blennow K, Ohrfelt A.

Mol Cell Proteomics. 2014 Jun 27. pii: mcp.M114.040113. [Epub ahead of print]

PMID:
24973420
[PubMed - as supplied by publisher]
Free Article
5.

Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease.

Mielke MM, Haughey NJ, Bandaru VV, Zetterberg H, Blennow K, Andreasson U, Johnson SC, Gleason CE, Blazel HM, Puglielli L, Sager MA, Asthana S, Carlsson CM.

Neurobiol Aging. 2014 May 27. pii: S0197-4580(14)00382-0. doi: 10.1016/j.neurobiolaging.2014.05.019. [Epub ahead of print]

PMID:
24952994
[PubMed - as supplied by publisher]
6.

Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative.

Noel-Storr AH, McCleery JM, Richard E, Ritchie CW, Flicker L, Cullum SJ, Davis D, Quinn TJ, Hyde C, Rutjes AW, Smailagic N, Marcus S, Black S, Blennow K, Brayne C, Fiorivanti M, Johnson JK, Köpke S, Schneider LS, Simmons A, Mattsson N, Zetterberg H, Bossuyt PM, Wilcock G, McShane R.

Neurology. 2014 Jul 22;83(4):364-373. Epub 2014 Jun 18. Review.

PMID:
24944261
[PubMed - as supplied by publisher]
7.

Neurological Assessment and Its Relationship to CSF Biomarkers in Amateur Boxers.

Neselius S, Brisby H, Marcusson J, Zetterberg H, Blennow K, Karlsson T.

PLoS One. 2014 Jun 18;9(6):e99870. doi: 10.1371/journal.pone.0099870. eCollection 2014.

PMID:
24941067
[PubMed - in process]
Free PMC Article
8.

Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke.

Hjalmarsson C, Bjerke M, Andersson B, Blennow K, Zetterberg H, Aberg ND, Olsson B, Eckerström C, Bokemark L, Wallin A.

J Cent Nerv Syst Dis. 2014 May 19;6:51-8. doi: 10.4137/JCNSD.S13821. eCollection 2014.

PMID:
24932109
[PubMed]
Free PMC Article
9.

Metabolite and Peptide Levels in Plasma and CSF Differentiating Healthy Controls from Patients with Newly Diagnosed Parkinson's Disease.

Trupp M, Jonsson P, Ohrfelt A, Zetterberg H, Obudulu O, Malm L, Wuolikainen A, Linder J, Moritz T, Blennow K, Antti H, Forsgren L.

J Parkinsons Dis. 2014 Jun 13. [Epub ahead of print]

PMID:
24927756
[PubMed - as supplied by publisher]
10.

Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample.

Kern S, Skoog I, Börjesson-Hanson A, Blennow K, Zetterberg H, Ostling S, Kern J, Gudmundsson P, Marlow T, Rosengren L, Waern M.

Brain Behav Immun. 2014 May 20. pii: S0889-1591(14)00128-7. doi: 10.1016/j.bbi.2014.05.006. [Epub ahead of print]

PMID:
24858658
[PubMed - as supplied by publisher]
11.

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL.

Lancet Neurol. 2014 Jun;13(6):614-29. doi: 10.1016/S1474-4422(14)70090-0.

PMID:
24849862
[PubMed - indexed for MEDLINE]
12.

Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid-β in Cerebrospinal Fluid.

Leinenbach A, Pannee J, Dülffer T, Huber A, Bittner T, Andreasson U, Gobom J, Zetterberg H, Kobold U, Portelius E, Blennow K; IFCC Scientific Division Working Group on CSF proteins.

Clin Chem. 2014 Jul;60(7):987-94. doi: 10.1373/clinchem.2013.220392. Epub 2014 May 19.

PMID:
24842955
[PubMed - in process]
13.

Monitoring concussion in a knocked-out boxer by CSF biomarker analysis.

Neselius S, Brisby H, Granholm F, Zetterberg H, Blennow K.

Knee Surg Sports Traumatol Arthrosc. 2014 May 13. [Epub ahead of print]

PMID:
24819180
[PubMed - as supplied by publisher]
14.

Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments.

Lista S, Zetterberg H, Dubois B, Blennow K, Hampel H.

J Neurol. 2014 Jun;261(6):1234-43. doi: 10.1007/s00415-014-7366-z. Epub 2014 May 8.

PMID:
24807087
[PubMed - in process]
15.

Neurochemical evidence of potential neurotoxicity after prophylactic cranial irradiation.

Kalm M, Abel E, Wasling P, Nyman J, Hietala MA, Bremell D, Hagberg L, Elam M, Blennow K, Björk-Eriksson T, Zetterberg H.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):607-14. doi: 10.1016/j.ijrobp.2014.03.019. Epub 2014 May 3.

PMID:
24803034
[PubMed - in process]
16.

The amyloid-β degradation pattern in plasma--a possible tool for clinical trials in Alzheimer's disease.

Pannee J, Törnqvist U, Westerlund A, Ingelsson M, Lannfelt L, Brinkmalm G, Persson R, Gobom J, Svensson J, Johansson P, Zetterberg H, Blennow K, Portelius E.

Neurosci Lett. 2014 Jun 24;573:7-12. doi: 10.1016/j.neulet.2014.04.041. Epub 2014 May 4.

PMID:
24796810
[PubMed - in process]
17.

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease.

Blennow K, Dubois B, Fagan AM, Lewczuk P, de Leon MJ, Hampel H.

Alzheimers Dement. 2014 May 2. pii: S1552-5260(14)00066-1. doi: 10.1016/j.jalz.2014.02.004. [Epub ahead of print] Review.

PMID:
24795085
[PubMed - as supplied by publisher]
18.

Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease.

Bradley P, Akehurst R, Ballard C, Banerjee S, Blennow K, Bremner J, Broich K, Cummings J, Dening K, Dubois B, Klipper W, Leibman C, Mantua V, Molinuevo JL, Morgan S, Muscolo LA, Nicolas F, Pani L, Robinson L, Siviero P, van Dam J, Van Emelen J, Wimo A, Wortmann M, Goh L.

Alzheimers Dement. 2014 Apr 18. pii: S1552-5260(14)00033-8. doi: 10.1016/j.jalz.2014.01.007. [Epub ahead of print]

PMID:
24751826
[PubMed - as supplied by publisher]
Free Article
19.

CSF Aβ42 predicts early-onset dementia in Parkinson disease.

Alves G, Lange J, Blennow K, Zetterberg H, Andreasson U, Førland MG, Tysnes OB, Larsen JP, Pedersen KF.

Neurology. 2014 May 20;82(20):1784-90. doi: 10.1212/WNL.0000000000000425. Epub 2014 Apr 18.

PMID:
24748671
[PubMed - indexed for MEDLINE]
20.

Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment.

Zetterberg H, Jakobsson J, Redsäter M, Andreasson U, Pålsson E, Ekman CJ, Sellgren C, Johansson AG, Blennow K, Landén M.

Psychiatry Res. 2014 Jul 30;217(3):143-6. doi: 10.1016/j.psychres.2014.03.045. Epub 2014 Apr 5.

PMID:
24745469
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk